Custom Monoclonal Antibodies
For Your Toughest Targets

Speed up the development of high-impact monoclonal antibodies with our phage
display wizardry and dedication to optimization.

From discovery research to lead identification for therapeutics and diagnostics
development, we are the team who can deliver the specificity, affinity, and functionality
few others can deliver.

NEW! COVID-19 nucleoprotein high-sensitivity (~2.5 pg) antibodies.
Updates on Abwiz COVID-19 Diagnostic and Therapeutic mAb Development

Our Custom
Antibody Services

Affinity maturation

Antibody Affinity
Maturation

rabbit

Rabbit Monoclonal
Antibodies (RabWiz)

Antibody humanization

Antibody Humanization
and Optimization

Accelerate success with phage
display wizardry

Larger libraries. Heightened affinity. Unique functionality.

By combining the versatility of phage display technology with the power of the rabbit immune response, our highly-engineered platform grants you access to even the rarest antibodies, fully optimized for your specific application by our team of experts.

Abwiz Bio Therapeutic
Antibody Development Plan

Accelerate the development of therapeutic lead candidates with our end-to-end solutions. Every step of our process is fully optimized and tailored to deliver exactly what you need.

Immunization

STEP 1

Immunization

Library Construction

STEP 2

Library
Construction
WizAmpTM

Panning & Screening

STEP 3

Panning &
Screening

Recombinant IgG production

STEP 4

Recombinant
IgG production

Humanization

STEP 5

Humanization

Affinity Maturation and Optimization

STEP 6

Affinity Maturation
and Optimization
StemTM

Immunization

STEP 1

Immunization

Library Construction

STEP 2

Library
Construction
WizAmpTM

Panning & Screening

STEP 3

Panning &
Screening

Recombinant IgG production

STEP 4

Recombinant
IgG production

Humanization

STEP 5

Humanization

Affinity Maturation and Optimization

STEP 6

Affinity Maturation
and Optimization
StemTM

Screenshot 2021-07-16 at 12.49 2@2x

About Abwiz

Group 206
Screenshot 2021-07-16 at 12.49 2@2x

We are a group of former drug discovery scientists who noticed that R&D teams were having a hard time getting highly successful antibodies, especially for tough targets, and we realized that some phage display wizardry could overcome those challenges.

Through our fully optimized services, we make rare monoclonal antibodies easily attainable.